Abstract
A rapid increase in obesity rates worldwide further underscores the importance of better understanding the pharmacokinetic alterations in this sub-population and the subsequent effects on pharmacotherapeutics. Pharmacokinetics of contraceptive steroids is altered in obese oral contraceptive users, which may in turn impact efficacy. Our study has identified several dosing strategies that offset these pharmacokinetic changes and may improve effectiveness for obese oral contraception users.
Original language | English (US) |
---|---|
Pages (from-to) | 1-3 |
Number of pages | 3 |
Journal | Expert Review of Clinical Pharmacology |
Volume | 8 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2014 |
Keywords
- drug failure
- obesity
- oral contraception
- pharmacokinetics
- steroidal hormones
ASJC Scopus subject areas
- General Pharmacology, Toxicology and Pharmaceutics
- Pharmacology (medical)